Y-Mabs Therapeutics Overview

Y-Mabs Therapeutics Research & Development

Research & Development expenses for YMAB.

Quarterly R&D Expenses

$11.10M

↓ 10.02% YoY

As of Jun 30, 2025

Annual R&D Expenses (TTM)

$45.84M

↓ 15.65% YoY

Trailing 12 months ending Jun 30, 2025

Average R&D Expenses (Comparison Companies)

Research & Development History

Research & Development Comparison

Annual Research & Development Growth Rate (%)

Annual Research & Development Growth (Absolute)

Jump to metric

Total Revenue Cost of Revenue Gross Profit Research & Development Selling, General & Admin Operating Income Other Income Expense Net EBIT Income Tax Net Income Profit Margin